NCOA4: An Immunomodulation-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

Figure 4

Relationship between the NCOA4 expression and the patients’ overall survival in various cancer types. (a) The forest plot of hazard ratios of NCOA4 in human pan-cancer. (b) OS survival map of various cancer types. The significant results of Kaplan–Meier curves are listed. (c) The expression of NCOA4 in alive and dead individuals with cancer types.

(a)

(b)

(c)